The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Initially a blockbuster drug, producing billions in sales , its intellectual property lapse created a flood of knock-off medications, significantly eroding its market share . While specific pharmaceutical companies may seek to capitalize on related treatme